JP Morgan Chase’s Genelux GNLX Stock Holding History
Bought
Maintained
Sold
Other funds holding GNLX
WDC
VCM
BL
FLPIM
VFT
CM
JP Morgan Chase's GNLX Position: Q1 2026 in Review
JP Morgan Chase increased its Genelux (GNLX) stake by 1,219% in Q1 2026, buying an estimated $864 and bringing the position to 343 shares worth $789. The position accounts for ﹤0.01% of the portfolio, ranked #7150.
JP Morgan Chase first reported a position in GNLX in Q1 2023 and has held it in 13 quarters since. The position peaked at $308K in Q3 2023. 71 funds tracked by Wall St. Rank hold GNLX as of Q1 2026.
- JP Morgan Chase held 343 shares of Genelux worth $789 as of Q1 2026.
- JP Morgan Chase bought 317 Genelux shares in Q1 2026, an estimated $864.
- Genelux made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #7150 holding.
- JP Morgan Chase first reported a position in Genelux in Q1 2023 and has held it in 13 quarters since.
- JP Morgan Chase's Genelux position peaked at $308K in Q3 2023.
- 71 funds tracked by Wall St. Rank held Genelux as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.